Stay Informed

Filter

Filter By

Reference Type

Author

A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcel

2023

Armstrong, N.; Olaye, A.; Noake, C.; Pang, F.

Orphanet J Rare Dis; 18: 248.

Read More

Digital interventions to moderate physical inactivity and/or nutrition in young people: a Cancer Prevention Europe overview of systematic reviews

2023

McDermott, K. T.; Noake, C.; Wolff, R.; Espina, C.; Foucaud, J.; Steindorf, K.; Schüz, J.; Thorat, M. A.; Weijenberg, M.; Bauld, L.; Kleijnen, J.

Frontiers in Digital Health; 5: 1185586.

Read More

Digital interventions to moderate alcohol consumption in young people: a Cancer Prevention Europe overview of systematic reviews

2023

McDermott, Kevin; Noake, Caro; Wolff, Robert; Espina, Carolina; Foucaud, Jerome; Steindorf, Karen; Schuz, Joachim; Thorat, Mangesh; Weijenberg, Matty; Bauld, Linda; Kleijnen, Jos

Frontiers in Digital Health; 5.

Read More

Oral azacitidine for maintenance treatment of acute myeloid leukaemia after induction therapy: an Evidence Review Group perspective of a NICE Single Technology Appraisal

2023

Witlox, W.; Grimm, S.; Howick, J.; Armstrong, N.; Ahmadu, C.; McDermott, K.; Otten, T.; Noake, C.; Wolff, R.; Joore, M.

Pharmacoeconomics; Epub ahead of print.

Read More

Pralsetinib for RET fusion-positive advanced non-small-cell lung cancer: an Evidence Review Group perspective of a NICE single technology appraisal

2023

Al Khayat, M. N. M. T.; Armstrong, N.; Howick, J.; O'Meara, S.; Posadzki, P.; Ryder, S.; Ahmadu, C.; Konings, S. R. A.; Postma, M. J.; Duffy, S.; Wolff, R. F.; van Asselt, A. D. I.

Pharmacoeconomics; Epub ahead of print.

Read More

Abemaciclib in combination with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer: an Evidence Review Group perspective of a NICE single technology appraisal

2023

Orozco Leal, G.; Armstrong, N.; Kernohan, A.; Ahmadu, C.; Coughlan, D.; McDermott, K.; Duffy, S.; O'Meara, S.; Robinson, T.; Vale, L.; Kleijnen, J.

Pharmacoeconomics; Epub ahead of print: 1-10.

Read More

Filgotinib for treating moderately to severely active ulcerative colitis: an evidence review group perspective of a NICE single technology appraisal

2023

van Asselt, A. D. I.; Armstrong, N.; Kimman, M.; Peeters, A.; McDermott, K.; Stirk, L.; Ahmadu, C.; Govers, T. M.; Hoentjen, F.; Joore, M. A.; Grimm, S. E.

Pharmacoeconomics; 41: 239-251.

Read More

PRISMA AI reporting guidelines for systematic reviews and meta-analyses on AI in healthcare

2023

Cacciamani, G. E.; Chu, T. N.; Sanford, D. I.; Abreu, A.; Duddalwar, V.; Oberai, A.; Kuo, C. J.; Liu, X.; Denniston, A. K.; Vasey, B.; McCulloch, P.; Wolff, R. F.; Mallett, S.; Mongan, J.; Kahn, C. E., Jr.; Sounderajah, V.; Darzi, A.; Dahm, P.; Moons, K. G. M.; Topol, E.; Collins, G. S.; Moher, D.; Gill, I. S.; Hung, A. J.

Nat Med; 29: 14-15.

Read More

Fenfluramine for treating Dravet syndrome: an Evidence Review Group perspective of a NICE single technology appraisal

2023

Wijnen, B.; Witlox, W.; Wolff, R.; Fayter, D.; Ramaekers, B.; Otten, T.; Ryder, S.; Posadzki, P.; Worthy, G.; Stirk, L.; Armstrong, N.; Kleijnen, J.; Joore, M.

Pharmacoeconomics; 41: 33-42.

Read More

Duration of protection after vaccination against yellow fever – systematic review and meta-analysis

2022

Kling, K.; Domingo, C.; Bogdan, C.; Duffy, S.; Harder, T.; Howick, J.; Kleijnen, J.; McDermott, K.; Wichmann, O.; Wilder-Smith, A.; Wolff, R.

Clin Infect Dis; 75: 2266-2274.

Read More

Role of the faecal immunochemical test in patients with risk-stratified suspected colorectal cancer symptoms: a systematic review and meta-analysis to inform the ACPGBI/BSG guidelines

2022

Booth, Richard; Carten, Rachel; D'Souza, Nigel; Westwood, Marie; Kleijnen, Jos; Abulafi, Muti

Lancet Reg Health Eur; 23: 100518.

Read More

SeHCAT (tauroselcholic [75selenium] acid) for the investigation of bile acid diarrhoea in adults: a systematic review and cost-effectiveness analysis

2022

Westwood, M.; Corro Ramos, I.; Armstrong, N.; Ryczek, E.; Penton, H.; Holleman, M.; Noake, C.; Al, M.

Health Technol Assess; 26: 1-192.

Read More

Identifying outcomes reported in trials of interventions in venous leg ulceration for a core outcome set development: a scoping review

2022

Hallas, S.; Nelson, E.A.; O'Meara, S.; Gethin, G.

J Tissue Viability; 31: 751-760.

Read More

Most healthcare interventions tested in Cochrane Reviews are not effective according to high quality evidence: a systematic review and meta-analysis

2022

Howick, J.; Koletsi, D.; Ioannidis, J.P.A.; Madigan, C.; Pandis, N.; Loef, M.; Walach, H.; Sauer, S.; Kleijnen, J.; Seehra, J.; Johnson, T.; Schmidt, S.

J Clin Epidemiol; 148: 160-9.

Read More

Osteopathic manipulative treatment for pediatric conditions: an update of systematic review and meta-analysis

2022

Posadzki, Pawel; Kyaw, Bhone Myint; Dziedzic, Arkadiusz; Ernst, Edzard

J Clin Med; 11: 4455.

Read More

Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG)

2022

Monahan, K. J.; Davies, M. M.; Abulafi, M.; Banerjea, A.; Nicholson, B. D.; Arasaradnam, R.; Barker, N.; Benton, S.; Booth, R.; Burling, D.; Carten, R. V.; D'Souza, N.; East, J. E.; Kleijnen, J.; Machesney, M.; Pettman, M.; Pipe, J.; Saker, L.; Sharp, L.; Stephenson, J.; Steele, R. J.

Gut; 71: 1939-1962.

Read More

Belimumab for treating active autoantibody-positive systemic lupus erythematosus: an Evidence Review Group perspective of a NICE single technology appraisal

2022

Otten, T.; Riemsma, R.; Wijnen, B.; Armstrong, N.; Stirk, L.; Gordon, C.; Ramaekers, B.; Kleijnen, J.; Joore, M.; Grimm, S.

Pharmacoeconomics; 40: 851-861.

Read More

Comparison of patients with head and neck cancer in randomized clinical trials and clinical practice: a systematic review

2022

Kaanders, J.H.A.M.; van den Bosch, S.; Kleijnen, J.

JAMA Otolaryngol Head Neck Surg; 148: 670-676.

Read More

QUAPAS: an adaptation of the QUADAS-2 tool to assess prognostic accuracy studies

2022

Lee, J.; Mulder, F.; Leeflang, M.; Wolff, R.; Whiting, P.; Bossuyt, P.M.

Ann Intern Med; 175: 1010-1018.

Read More

Guideline for the diagnosis and treatment of Faecal Incontinence-A UEG/ESCP/ESNM/ESPCG collaboration

2022

Assmann, S.L.; Keszthelyi, D.; Kleijnen, J.; Anastasiou, F.; Bradshaw, E.; Brannigan, A.E.; Carrington, E.V.; Chiarioni, G.; Ebben, L.D.A.; Gladman, M.A.; Maeda, Y.; Melenhorst, J.; Milito, G.; Muris, J.W.M.; Orhalmi, J.; Pohl, D.; Tillotson, Y.; Rydningen, M.; Svagzdys, S.; Vaizey, C.J.; Breukink, S.O.

United European Gastroenterol J; 10: 251-86.

Read More

A scattered landscape: assessment of the evidence base for 71 patient decision aids developed in a hospital setting

2022

Danner, M.; Debrouwere, M.; Rummer, A. ; Wehkamp, K.; Rüffer, J.U.; Geiger, F.; Wolff, R.; Weik, K.; Scheibler, F.

BMC Med Inform Decis Mak; 22: 44.

Read More

Belimumab for treating active autoantibody-positive systemic lupus erythematosus: an Evidence Review Group perspective of a NICE STA

2022

Otten, T.; Riemsma, R.; Wijnen, B.; Armstrong, N.; Stirk, L.; Gordon, C.; Ramaekers, B.; Kleijnen, J. et al.

Pharmacoeconomics;40:851-861.

Read More

Living systematic reviews in rehabilitation science can improve evidence-based healthcare

2021

Elbers, S.; Wittink, H.; Kaiser, U.; Kleijnen, J.; Pool, J.; Köke, A.; Smeets, R.

Syst Rev; 10: 309.

Read More

Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis

2021

Swift, S.L.; Puehler, T.; Misso, K.; Lang, S.H.; Forbes, C.; Kleijnen, J.; Danner, M.; Kuhn, C.; Haneya, A.; Seoudy, H.; Cremer, J.; Frey, N.; Lutter, G.; Wolff, R.; Scheibler, F.; Wehkamp, K.; Frank, D.

BMJ Open; 11: e054222.

Read More